JP2009501777A5 - - Google Patents

Download PDF

Info

Publication number
JP2009501777A5
JP2009501777A5 JP2008522096A JP2008522096A JP2009501777A5 JP 2009501777 A5 JP2009501777 A5 JP 2009501777A5 JP 2008522096 A JP2008522096 A JP 2008522096A JP 2008522096 A JP2008522096 A JP 2008522096A JP 2009501777 A5 JP2009501777 A5 JP 2009501777A5
Authority
JP
Japan
Prior art keywords
mixture
optionally
mixtures
alcohol
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008522096A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009501777A (ja
JP5199084B2 (ja
Filing date
Publication date
Priority claimed from EP05291542A external-priority patent/EP1745775B1/en
Application filed filed Critical
Publication of JP2009501777A publication Critical patent/JP2009501777A/ja
Publication of JP2009501777A5 publication Critical patent/JP2009501777A5/ja
Application granted granted Critical
Publication of JP5199084B2 publication Critical patent/JP5199084B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008522096A 2005-07-19 2006-07-19 胃保持型製剤およびそれらの製造方法 Expired - Fee Related JP5199084B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05291542.8 2005-07-19
EP05291542A EP1745775B1 (en) 2005-07-19 2005-07-19 Gastroretentive formulations and manufacturing process thereof.
PCT/IB2006/002636 WO2007010400A2 (en) 2005-07-19 2006-07-19 Gastroretentive formulations and manufacturing process thereof

Publications (3)

Publication Number Publication Date
JP2009501777A JP2009501777A (ja) 2009-01-22
JP2009501777A5 true JP2009501777A5 (https=) 2011-03-31
JP5199084B2 JP5199084B2 (ja) 2013-05-15

Family

ID=35517256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008522096A Expired - Fee Related JP5199084B2 (ja) 2005-07-19 2006-07-19 胃保持型製剤およびそれらの製造方法

Country Status (12)

Country Link
US (1) US9629800B2 (https=)
EP (2) EP1745775B1 (https=)
JP (1) JP5199084B2 (https=)
KR (1) KR101367814B1 (https=)
CN (1) CN101237858B (https=)
AT (1) ATE396710T1 (https=)
AU (1) AU2006271314B2 (https=)
BR (1) BRPI0612901B8 (https=)
CA (1) CA2616081C (https=)
DE (1) DE602005007205D1 (https=)
RU (1) RU2376983C2 (https=)
WO (1) WO2007010400A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
WO2010038237A2 (en) 2008-09-22 2010-04-08 Rubicon Research Private Limited Compositions exhibiting delayed transit through the gastrointestinal tract
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
CA2767143A1 (en) 2009-07-06 2011-01-13 Kyorin Pharmaceutical Co., Ltd. Tablet having hollow structure
EP2361615A1 (en) 2010-02-19 2011-08-31 Alfred E. Tiefenbacher GmbH & Co. KG Dipyridamole prolonged-release tablet
WO2011111068A2 (en) 2010-03-09 2011-09-15 Council Of Scientific And Industrial Research Gastroretentive, extended release composition of therapeutic agent
KR101767288B1 (ko) * 2010-03-31 2017-08-10 모찌다 세이야쿠 가부시끼가이샤 복용 용이성 고형 제제
CN101919817B (zh) * 2010-07-23 2012-05-30 山东齐都药业有限公司 一种拉呋替丁胃内滞留控制释放组合物
WO2013046453A1 (ja) 2011-09-30 2013-04-04 持田製薬株式会社 易服用性固形製剤
DE102012102414A1 (de) 2012-03-21 2013-10-10 Michael Dittgen Pharmazeutische Zusammensetzung für die einmal tägliche Anwendung antidiabetischer Arzneimittel wie Metformin mit Zwei-Puls-Freisetzung
WO2013168179A2 (en) * 2012-04-03 2013-11-14 Rubicon Research Private Limited Controlled release pharmaceutical formulations of antiviral agents
CN103110601B (zh) * 2013-02-04 2014-10-29 成都恒瑞制药有限公司 一种格列齐特胃漂浮片及其制备方法
FR3014692B1 (fr) * 2013-12-18 2016-01-29 Ethypharm Sa Compositions pharmaceutiques orales a retention gastrique.
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
JP7418958B2 (ja) 2016-03-17 2024-01-22 チオジェネシス セラピューティクス， インコーポレイテッド システアミンの制御放出のための組成物及びシステアミン感受性障害の全身治療
CN107184560B (zh) * 2017-06-03 2021-02-02 寿光富康制药有限公司 二甲双胍胃滞留片及制备方法
JP7208982B2 (ja) 2017-09-20 2023-01-19 チオジェネシス セラピューティクス， インコーポレイテッド システアミン感受性障害の治療方法
WO2019126216A1 (en) 2017-12-18 2019-06-27 Tris Phama, Inc. Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
EP3737353A1 (en) 2017-12-18 2020-11-18 Tris Pharma, Inc. Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
US11337919B2 (en) 2017-12-18 2022-05-24 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive RAFT forming systems having trigger pulse drug release
WO2019126214A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
CN109602714B (zh) * 2018-12-29 2020-06-12 广东中润药物研发有限公司 一种利伐沙班胃滞留片及其制备方法
GB2599950A (en) * 2020-10-16 2022-04-20 Zentiva Ks Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
JP2024502378A (ja) * 2021-01-13 2024-01-18 デュポン・ニュートリション・ユーエスエイ，インコーポレイテッド 胃内滞留型薬物送達系

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61148115A (ja) * 1984-12-21 1986-07-05 Tooa Eiyoo Kk 難溶性薬物の徐放性製剤及びその製造法
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
FR2653337B1 (fr) * 1989-10-23 1992-02-07 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
US6635280B2 (en) 1997-06-06 2003-10-21 Depomed, Inc. Extending the duration of drug release within the stomach during the fed mode
PT1003476E (pt) * 1997-08-11 2005-05-31 Alza Corp Forma de dosagem de agente activo de libertacao prolongada adaptada para retencao gastrica
IN186245B (https=) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
EP1063973B1 (en) 1998-03-19 2016-11-16 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
ATE245414T1 (de) * 1998-09-14 2003-08-15 Ranbaxy Lab Ltd Oral verabreichtes system zur zeitlich und räumlich gesteuerten arzneistoffabgabe
US6797283B1 (en) 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
EP1140027B1 (en) * 1998-12-23 2005-10-12 Alza Corporation Dosage forms comprising porous particles
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
HUP0204417A3 (en) * 2000-03-03 2005-03-29 Ranbaxy Lab Ltd Oral ciprofloxacin-composition of controlled release
WO2003097018A1 (en) * 2002-02-04 2003-11-27 Ranbaxy Laboratories Limited Hydrodynamically balancing oral drug delivery system with biphasic release
MXPA03012041A (es) * 2001-07-04 2004-03-26 Sun Pharmaceutical Ind Ltd Sistema de administracion controlada de farmacos de retencion gastrica.
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
WO2003101431A1 (en) 2002-06-04 2003-12-11 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
WO2005060942A1 (en) * 2003-12-19 2005-07-07 Aurobindo Pharma Ltd Extended release pharmaceutical composition of metformin

Similar Documents

Publication Publication Date Title
JP2009501777A5 (https=)
WO2006100281A3 (en) Solubilized ibuprofen
ES2655435T3 (es) Formulación de disolución rápida de cinacalcet
JP2005509052A5 (https=)
RU2016128216A (ru) Покрытая пленкой таблетка, содержащая холина альфосцерат, и способ ее изготовления
JP2007302683A5 (https=)
MX2010004292A (es) Producto de dispersion solida que contiene un compuesto a base de n-aril urea.
JP2006077018A5 (https=)
ES2768349T3 (es) Preparación farmacéutica que comprende un derivado de fenilalanina
WO2005049681A3 (en) Antireflective coatings for via fill and photolithography applications and methods of preparation thereof
TW200503786A (en) Fast dissolving orally consumable films containing a modified starch for improved heat and moisture resistance
RU2008106220A (ru) Гастроретентивные композиции и способ их изготовления
RU2010101797A (ru) Фармацевтический твердый препарат, содержащий бензазепины и способ его получения
WO2007143163A3 (en) Pharmaceutical compositions for sustained release of phenyephrine
WO2015115453A1 (ja) 口腔内速崩壊性固形製剤用組成物
DE60306120D1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
BRPI0717914A2 (pt) "metodo de formação de um comprimido"
CN103462926B (zh) 一种泛昔洛韦片剂及其制备方法
WO2008100240A3 (en) Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
JP2010202579A (ja) アカルボースを含有する口腔内崩壊剤
EA200901191A1 (ru) Фармацевтическая композиция, содержащая активный ингредиент аторвастатин
WO2006101794A3 (en) Stable tablet dosage forms of proton pump inhibitors
RU2008136656A (ru) Способ изготовления лекарственного препарата в форме таблеток на основе миансерина гидрохлорида, препарат, полученный этим способом, и его кристаллическая структура
RU2007133793A (ru) Составы с контролируемым высвобождением альфузозина
IL182549A0 (en) Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby